Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Long-lived assets by geography
Long-lived assets (PP&E and operating lease ROU assets) by geography — Total ($M) ($M)
Vertex Pharmaceuticals Long-lived assets by geography: $3,083M in FY2025, up 19.3% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Segment & Geographic Information Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-lived assets (PP&E and operating lease ROU assets) by geography — Total ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,083 | +19.3% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 2,585 | +77.9% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 1,453 | -0.2% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 1,456 | +2.2% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 1,424 | +10.9% | Form 10-K (filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 1,284 | +54.1% | Form 10-K (filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 833 | +2.6% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 812 | +2.9% | Form 10-K (filed 2020-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 789 | +13.0% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 698 | +0.1% | Form 10-K (filed 2018-02-15) ↗ |
| FY2015 | Dec 31, 2015 | 698 | – | Form 10-K (filed 2017-02-23) ↗ |
Breakdown
What makes up long-lived assets by geography
Cite this data
StockData. (2026). Vertex Pharmaceuticals Long-lived assets by geography ($M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/geo-lla-tot
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.